Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-8kt4b Total loading time: 0 Render date: 2024-06-16T05:43:08.894Z Has data issue: false hasContentIssue false

Circadian Regulators

from Part II - Medication Reference Tables

Published online by Cambridge University Press:  19 October 2021

Edited by
Michael Cummings  and
Stephen Stahl
Michael Cummings
Affiliation:
University of California, Los Angeles
Stephen Stahl
Affiliation:
University of California, San Diego
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Management of Complex Treatment-resistant Psychotic Disorders , pp. 393 - 403
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Herxheimer, A. (2014). Jet lag. BMJ Clin Evid, 2014, 2303.Google ScholarPubMed
Hansen, M. V., Halladin, N. L., Rosenberg, J., et al. (2015). Melatonin for pre- and postoperative anxiety in adults. Cochrane Database Syst Rev, 2015(4), CD009861.Google ScholarPubMed
Auld, F., Maschauer, E. L., Morrison, I., et al. (2017). Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Med Rev, 34, 10–22.Google Scholar
Erland, L. A., Saxena, P. K. (2017). Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. J Clin Sleep Med, 13, 275–281.CrossRefGoogle ScholarPubMed
Posadzki, P. P., Bajpai, R., Kyaw, B. M., et al. (2018). Melatonin and health: an umbrella review of health outcomes and biological mechanisms of action. BMC Med, 16, 18.CrossRefGoogle ScholarPubMed
Pierce, M., Linnebur, S. A., Pearson, S. M., et al. (2019). Optimal melatonin dose in older adults: a clinical review of the literature. Sr Care Pharm, 34, 419–431.CrossRefGoogle ScholarPubMed
Tordjman, S., Chokron, S., Delorme, R., et al. (2017). Melatonin: pharmacology, functions and therapeutic benefits. Curr Neuropharmacol, 15, 434–443.CrossRefGoogle ScholarPubMed
Riha, R. L. (2018). The use and misuse of exogenous melatonin in the treatment of sleep disorders. Curr Opin Pulm Med, 24, 543–548.CrossRefGoogle ScholarPubMed
Andersen, L. P., Werner, M. U., Rosenkilde, M. M., et al. (2016). Pharmacokinetics of oral and intravenous melatonin in healthy volunteers. BMC Pharmacol Toxicol, 17, 8.CrossRefGoogle ScholarPubMed
Costello, R. B., Lentino, C. V., Boyd, C. C., et al. (2014). The effectiveness of melatonin for promoting healthy sleep: a rapid evidence assessment of the literature. Nutr J, 13, 106.CrossRefGoogle ScholarPubMed
Andersen, L. P., Gogenur, I., Rosenberg, J., et al. (2016). The safety of melatonin in humans. Clin Drug Investig, 36, 169–175.CrossRefGoogle ScholarPubMed

References

Borja, N. L., Daniel, K. L. (2006). Ramelteon for the treatment of insomnia. Clin Ther, 28, 1540–1555.CrossRefGoogle ScholarPubMed
Low, T. L., Choo, F. N., Tan, S. M. (2020). The efficacy of melatonin and melatonin agonists in insomnia – an umbrella review. J Psychiatr Res, 121, 10–23.CrossRefGoogle ScholarPubMed
Erman, M., Seiden, D., Zammit, G., et al. (2006). An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia. Sleep Med, 7, 17–24.CrossRefGoogle ScholarPubMed

References

Stahl, S. M. (2017). Tasimelteon. In Stahl’s Essential Psychopharmacology Prescriber’s Guide (eds.). Cambridge: Cambridge University Press, pp. 699–701.Google Scholar
Vanda Pharmaceuticals Inc. (2019). Tasimelteon Package Insert. Washington, D.C.Google Scholar
Low, T. L., Choo, F. N., Tan, S. M. (2020). The efficacy of melatonin and melatonin agonists in insomnia – an umbrella review. J Psychiatr Res, 121, 10–23.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×